期刊文献+

生长抑素在儿童先天性心脏病术后乳糜胸保守治疗中的应用 被引量:1

Application of somatostatin in expectant treatment for postoperative chylothorax in children after congenital heart disease surgery
原文传递
导出
摘要 目的研究生长抑素在儿童先天性心脏病术后乳糜胸保守治疗中的临床疗效。方法回顾性分析2003年1月至2012年12月武汉市儿童医院收治的先天性心脏病术后并发乳糜胸的13例患儿临床资料,2009年前采用常规治疗(对照组,6例),2009年后采用生长抑素治疗(治疗组,7例),2组患儿年龄、体质量、术后发生乳糜胸时间等一般资料比较,差异均无统计学意义,乳糜胸诊断标准一致。分析比较2组病例治疗前、治疗中乳糜胸引量变化、治愈时间等指标。结果对照组6例乳糜胸患儿中3例经保守治疗临床治愈,3例保守治疗无效(2例手术治疗痊愈,1例死亡)。对照组乳糜胸引量在治疗后1周[(155.5±85.7)mL/d]及2周[(142.3±110.3)mL/d]较治疗前[(256.6±124.2)mL/d]减少(t=4.623、2.099,P=0.002、0.044)。对照组乳糜胸引量治疗3周后[(139.4±113.4)mL/d]较治疗前无明显减少(t=1.745,P=0.07)。治疗组6例保守治疗成功,1例手术后痊愈。治疗组乳糜胸引量在治疗后1周[(51.2±18.7)mL/d]及2周[(19.3±7.05)mL/d]较治疗前[(300.3±115.6)mL/d]明显减少(t=5.549、6.638,P=0.001、0.001)。2组胸引革在治疗后1周、2周比较差异均有统计学意义(t=2.900、2.412,P=0.014、0.034)。2组保守治愈病例术后痊愈时间[(32.8±1.8)d比(25.2±1.7)d]差异有统计学意义(t=2.512,P:0.028)。结论生长抑素能促进婴幼儿术后乳糜胸恢复,在早期保守治疗中应积极使用。 Objective To investigate the therapeutic efficacy of somatostatin on chylothorax after congenital heart disease surgery in children. Methods Retrospective analysis was pertormed in 13 postoperative chylothorax cases from Jan. 2003 to Dec. 2012, who were divided into control group (n = 6 ) and treatment group (n = 7 ) , and there was no significant difference in age, weight, and time of occurrence between the 2 groups. The diagnosis standard for chylo- thorax was the same. The changes of chylous volume during the treatment were analyzed between 2 groups, and healing time and other data were analyzed too. Results Control group:clinical cure in 3 cases,conservative treatment failed in 3 cases(2 cases recovered after operation and 1 case died). The chyle volume of control group reduced obviously com- pared with post treatment from beginning [ (256.6 ± 124.2) mL/d ] to 1 week [ ( 155.5 ± 85.7 ) mL/d ] and 2 weeks [ ( 142.3 ± 110.3) mL/d] later( t =4. 623,2. 099;P =0. 002,0. 044). But it did not reduce obviously in 3 weeks later [ ( 139.4 ± 113.4 ) mL/d ] ( t = 1. 745,P = 0.07 ). Treatment group : 6 cases in treatment group were successful in recovery after conservative treatment and 1 case underwent operation. The chyle volume of treatment group reduced obviously compared with post treatment from beginning to 1 week [ (51.2 ± 18.7) mL/dl and 2 weeks [ ( 19.3 ± 7.05 ) mL/d I later ( t = 5. 549,6. 638 ;P = 0. 001,0. 001 ). Compared with the control group, the difference between 2 groups in post treatment( 1 week later,2 weeks later) was of statistical significance(t = 2. 900,2. 412;P =0. 014, 0. 034). The healing time of conservative treatment in 2 groups ( only for recovery) had obvious difference [ ( 32.8 ± 1.8 ) d, (25.2 ± 1.7 ) d] ( t= 2.512,P = 0. 028 ). Conclusions The use of somatostatin can significantly promote the recovery of chylothorax in children,and it should be actively used in early conservative treatment.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2014年第5期354-356,共3页 Chinese Journal of Applied Clinical Pediatrics
关键词 生长抑素 乳糜胸 心脏病 先天性 胸导管结扎 儿童 Somatostatin Chylothorax Congenital heart disease Thoracic duct ligation Child
  • 相关文献

参考文献17

  • 1汪力,皮名安,龚立,王涛.奥曲肽在婴幼儿心胸手术后乳糜胸治疗中的临床应用[J].中华小儿外科杂志,2012,33(8):582-585. 被引量:3
  • 2方震宇,夏军,彭涛,罗彬,黄杰,康敢军,程邦昌.医源性乳糜胸的外科治疗[J].临床外科杂志,2013,21(1):43-45. 被引量:5
  • 3付雪梅,巨容.新生儿乳糜胸的诊治策略[J].实用儿科临床杂志,2010,25(14):1040-1042. 被引量:8
  • 4Juszczyk K,Waugh R,Sandroussi C. Lymphangiography as therapeutic management of chylothorax[J].J Med Imaging Radiat Oncol,2013,(04):460-461.
  • 5Liou DZ,Warren H,Maher DP. Midodrine:a novel therapeutic for refractory chylothorax[J].CHEST,2013,(03):1055-1057.
  • 6Matsuo S,Takahashi G,Konishi A. Management of refractory chylothorax after pediatric cardiovascular surgery[J].Pediatric Cardiology,2013,(05):1094-1099.
  • 7Sekine Y. Surgical management of chylothorax after pulmonary resection[J].Kyobu Geka Japanese Journal of Thoracic Surgery,2013,(8 Suppl):S741-S744.
  • 8Jiang H,Deng XF,Duan CM. Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct[J].LYMPHOLOGY,2011,(01):21-28.
  • 9Choo YM,Lim CT. Treatment of congenital chylothorax with octreotide in a hydropic preterm infant[J].Paediatr Int Child Health,2013,(02):116-119.
  • 10López López MV,Luengo Pérez LM,Rangel Mayoral JF. Efficacy and safety of adjuvant octreotide with parenteral nutrition for conservative treatment of chylothorax[J].Nutricion Hospitalaria,2012,(03):948-949.

二级参考文献42

  • 1冯超,汤恢焕,陈子华,吕新生.217例重症急性胰腺炎的治疗[J].中国普通外科杂志,2005,14(5):334-336. 被引量:24
  • 2张圣道,雷若庆.重症急性胰腺炎诊治指南[J].中华外科杂志,2007,45(11):727-729. 被引量:1147
  • 3张盛洪,钟碧慧,陈旻湖.重症急性胰腺炎的诊治现状[J].实用医学杂志,2007,23(11):1601-1603. 被引量:6
  • 4Abrams ME, Meredith KS, Kinnard P,et al. Hydrops fetalis:A retrospective review of cases reported to a large national database and identification of risk factors associated with death [ J ]. Pediatrics,2007,120 ( 1 ) : 84 - 89.
  • 5Copons Fernandez C, Benftez Segura I, Castillo Salinas F, et al, Neonatal chylothorax : Aetiology, clinical course and efficacy of treatment [ J ]. An Pediatr (Barc) ,2008,68 (3) :224 - 231.
  • 6Paes ML, Powell H. Chylothorax: An update [J]. Br J Hosp Med, 1994, 51 (9) :482 -490.
  • 7Zilversmit DB. The composition and structure of lymph chylomicrons in dog,rat,and man[J]. J Clin Invest, 1965,44(10) :1610 - 1622.
  • 8Rahman NM, Chapman- SJ, Davies RJ. Pleural" effusion: A structured ap- proach to care[ J]. Br Med Bull,2005,72:31 -47.
  • 9Femandez Alvarez JR, Kalache KD, GraVel EL. Management of spontaneous congenital chylothorax: Oral medium -chain triglycerides versus total parenteral nutrition [ J ]. Am J Perinatol, 1999,16 ( 8 ) :415 - 420.
  • 10熊滨,张志雄,韩林,林勇军,卢国浩,庞静.生长抑素联合乌司他丁治疗重症急性胰腺炎的临床研究[J].中国危重病急救医学,2007,19(8):498-499. 被引量:9

共引文献66

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部